RemedyBio’s CSO Dr. Paul Leonard is leading an independent validation study of commercially available COVID-19 serological tests, with the aim of recommending the best in class tests for nationwide seroprevalence studies in Ireland. This project is funded by DCU’s COVID-19 Research and Innovation Hub.
Remedy BiologicsMay 11, 2023
RemedyBio today announces a research and evaluation agreement with GSK
Remedy BiologicsDecember 13, 2022
RemedyBio announces participation in INSPIRE and successful grant funding
Remedy BiologicsDecember 6, 2022